Wichterman Troy's Form 4 filing
Biolife Solutions Inc (BLFS) · filed Jan 11, 2022
- Accession no.
- 0001437749-22-000744
- Filed
- Jan 11, 2022
- Trade date
- Jan 7, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $1.45K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001437749-22-003761 (Feb 17, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wichterman TroyCIK 0001892616 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2022 | Common Stock | SSaleAcquired | +47 | $30.75 | +$1,445.25 | 22,075 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.